Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1632
This examiner grants 30% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17914246 | ENTERIC NITRERGIC NEURONS AND METHODS OF USING THE SAME | Non-Final OA | The Regents of the University of California |
| 18012959 | METHOD FOR PREPARING COMPOSITION FOR CULTURING PANCREATIC ORGANOIDS, COMPOSITION THEREFOR, AND METHOD FOR CULTURING ORGANOIDS BY USING SAME | Non-Final OA | POSTECH RESEARCH AND BUSINESS DEVELOPMENT FOUNDATION |
| 18021156 | EX VIVO BRAIN TUMOR MODEL | Non-Final OA | Massachusetts Institute of Technology |
| 17434186 | ENGINEERED IMMUNE CELLS | Final Rejection | NATIONAL UNIVERSITY OF SINGAPORE |
| 17772539 | PROTEASE SWITCH FOR DUAL TARGETS CHIMERIC ANTIGEN RECEPTOR T CELL THERAPY | Final Rejection | THE TEXAS A&M UNIVERSITY SYSTEM |
| 17904381 | METHOD FOR PREPARING FIBROSIS-ENCAPSULATED TUMOROID, AND USE THEREOF | Final Rejection | INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY |
| 17421908 | COMPOSITIONS AND METHODS FOR TREATMENT OF A MALABSORPTIVE DISORDER | Non-Final OA | CHILDREN'S HOSPITAL MEDICAL CENTER |
| 17429215 | PHARMACEUTICAL COMPOSITION FOR PREVENTING IN-STENT RESTENOSIS | Non-Final OA | Nipro Corporation |
| 18043507 | METHOD OF PRODUCING THREE-DIMENSIONAL TISSUE BODY AND THREE-DIMENSIONAL TISSUE BODY | Non-Final OA | OSAKA UNIVERSITY |
| 17251587 | USE OF FIBROBLASTS AND/OR MODIFIED FIBROBLASTS FOR THREE DIMENSIONAL TISSUE PRINTING | Non-Final OA | Figene, LLC |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy